Kofax Ltd. (KFX) 11.01 $KFX KFx Awarded a Third Patent

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kofax Ltd. (KFX) 11.01 $KFX

KFx Awarded a Third Patent for Self-Punching Orthopedic Anchors - US 9,414,835
BusinessWire - Fri Aug 26, 11:21AM CDT
KFx announced that it has been awarded a third patent (US 9,414,835 ('835)) for self-punching or self-tapping orthopedic anchors that eliminate the need to drill a hole prior to insertion. US ('835) is part of the family of patents that are the subject of KFx's pending patent infringement suit against Arthrex, a Naples, Florida based company.
KFX: 11.01 (+0.02)

Conmed Purchases AppianFx Anchor System from KFx
BusinessWire - Fri Dec 04, 10:28AM CST
KFx announced today the completion of the sale of AppianFx, a unique soft tissue fixation system, to Conmed Corporation. The transaction consideration was not disclosed.
KFX: 11.01 (+0.02)

KFx Announces Win at United States Supreme Court
BusinessWire - Tue Nov 17, 6:00AM CST
KFx Medical announced that a petition for writ of certiorari filed by Arthrex was denied by the Supreme Court of the United States. The Supreme Court refused Arthrex's request for review of a patent infringement judgment in favor of KFx Medical.
KFX: 11.01 (+0.02)

CORRECTING and REPLACING KFx Announces New Patent Infringement Suit against Arthrex
BusinessWire - Tue Sep 08, 5:29PM CDT
Please replace the release with the following corrected version due to multiple revisions.
KFX: 11.01 (+0.02)

KFx Announces New Patent Infringement Suit against Arthrex
BusinessWire - Tue Sep 08, 9:00AM CDT
KFx announces new patent infringement suit against Arthrex.
KFX: 11.01 (+0.02)

KFx Medical Receives $35 Million Payment From Arthrex
BusinessWire - Wed Jun 17, 3:00PM CDT
KFx Medical announced that it received $35 million from Arthrex in payment for the judgment by the United States District Court for the Southern District of California in which a jury found that Arthrex infringed KFx's U.S. Patent No. 7,585,311 and two other patents, found the patents were valid, and awarded $29 million in damages. In April 2015 the US Court of Appeals reaffirmed their Jan. 20, 2015 ruling upholding a judgment of the United States District Court for the Southern District of California and denied Arthrex's petition for en banc rehearing and issued a mandate to enforce the judgment.
JNJ: 119.32 (+0.24), KFX: 11.01 (+0.02)

Smart Process Application Market by Solution, Service, Deployment Type, Organization Size, Verticals, & Regions - Global Forecast to 2020
M2 - Fri Jun 12, 5:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bkbb7r/smart_process) has announced the addition of the "Smart Process Application Market by Solution, by Service, by Deployment Type, by Organization Size, by Verticals, & by Region - Global Forecast to 2020" report to their offering. The smart process application market is expected to grow from $24.35 billion in 2015 to $43.28 billion in 2020. This represents a Compound Annual Growth Rate (CAGR) of 12.19% from 2015 to 2020. The table and figures below highlight the overall market opportunity in the market (2015-2020) The smart process applications are special type of application software that is designed to enable the organizations to smartly handle the process that are informative, unstructured, and human intensive in efficient and compliant manner. The revenue from the SPA-based market has been consistent over the past one year and is expected to gain traction in the next five years, due to increasing new product launches and mergers and acquisition by the existing players. The major areas of opportunities for these applications include increasing business complexity and customer on boarding that will play a crucial role in the growth of smart process application market. North America (NA) is expected to continue to hold its market position with highest regional market share, followed by the Europe region. However, the APAC region is expected to witness the highest growth rate in the market. It is expected that verticals such as BFSI, public sector, energy and utilities, manufacturing, retail, healthcare and telecom & IT will occupy the leading market share in the overall smart process application market. Technological developments in ICT, connectivity, mobile devices and increasing business agility will remain the main drivers behind increased adoption of smart process application solutions. Through these solutions, organizations can avail benefits such as structured process and accelerated processing times to better manage and grow their business. The prominent solution developers in this domain are EMC Corporation, OpenText, Appian, SAP, KANA, Lexmark International, Salesforce.com, and Kofax. These players along with the others present in the market are expected to make a big impact in this rapidly growing marketplace in the next 5 years. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Smart Process Application Market By Solution 8 Smart Process Application Market By Services 9 Smart Process Application Market By Deployment Type 10 Smart Process Application Market, By Organization Size 11 Smart Process Application Market By Vertical 12 Smart Process Application Market By Regions 12 Competitive Landscape 13 Company Profiles - Appian - EMC Corporation - IBM - Kana - Kofax Limited - Lexmark International - Opentext Corp - Salesforce.Com - SAP For more information visit http://www.researchandmarkets.com/research/bk...rt_process
IBM: 159.55 (+0.01), EMC: 28.77 (-0.09), CRM: 75.10 (-0.81), KFX: 11.01 (+0.02)

Lexmark buys Kofax
M2 - Fri May 22, 10:04AM CDT
Lexmark International, Inc. (NYSE: LXK) said it has closed on its acquisition of Kofax Limited.
LXK: 36.27 (+0.06), KFX: 11.01 (+0.02)

Lexmark completes acquisition of Kofax, announces Enterprise Software leadership change
PR Newswire - Thu May 21, 10:00AM CDT
-- Lexmark International, Inc. today announced that it has closed on its acquisition of Kofax Limited. Lexmark acquired Kofax in a cash transaction for $11.00 per share, for a total enterprise value of approximately $1 billion. This acquisition will nearly double the size of Lexmark's Enterprise Software annualized revenue to approximately $700 million.
LXK: 36.27 (+0.06), KFX: 11.01 (+0.02)

Leading Global Engineering Firm Invests More than $1.2 Million in Kofax TotalAgility and Kofax MarkView
BusinessWire - Wed May 20, 7:00AM CDT
Kofax(R) Limited (NASDAQ: KFX), a leading provider of software to simplify and transform the First Mile(TM) of customer engagement, today announced that a global engineering, architecture and environmental firm has invested more than $1.2 million in Kofax TotalAgility(R) and Kofax MarkView(R) to streamline operations, automate manual processes, improve employee efficiency and reduce costs.
KFX: 11.01 (+0.02)

U.S. State Tax Agency Invests More than $380,000 in Kofax TotalAgility
BusinessWire - Thu May 14, 7:00AM CDT
Kofax(R) Limited (NASDAQ: KFX), a leading provider of software to simplify and transform the First Mile(TM) of customer engagement, today announced that a U.S. state tax agency has invested more than $380,000 in Kofax TotalAgility(R) and Kofax Analytics for Total Agility(R) to automate manual processes and improve staff efficiency.
KFX: 11.01 (+0.02)

Lexmark, Kofax get HSR clearance for proposed transaction
M2 - Mon May 11, 8:47AM CDT
Lexmark International, Inc. (NYSE: LXK) and Kofax Limited (NASDAQ: KFX) said that the applicable waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 has expired with respect to Lexmark's proposed acquisition of Kofax via merger.
KFX: 11.01 (+0.02), LXK: 36.27 (+0.06)

Kofax to Highlight Its New Web-enabled Mobile Capture Solution for Streamlined Account Onboarding at FinovateSpring 2015
BusinessWire - Mon May 11, 7:00AM CDT
Kofax Limited:
KFX: 11.01 (+0.02)

Lexmark and Kofax announce HSR clearance for proposed transaction
PR Newswire - Fri May 08, 3:30PM CDT
-- Lexmark International, Inc. and Kofax Limited (NASDAQ: KFX) today announced that the applicable waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 has expired with respect to Lexmark's proposed acquisition of Kofax via merger.
LXK: 36.27 (+0.06), KFX: 11.01 (+0.02)

Pre-market Insights on Software Industry Stocks - Electronic Arts, Take-Two Interactive Software, TiVo Inc., Qlik Technologies, and Kofax
PR Newswire - Fri May 08, 7:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
TTWO: 44.70 (+0.94), TIVO: 11.02 (+0.33), EA: 83.46 (+1.70), QLIK: 30.50 (+0.02), KFX: 11.01 (+0.02)

Global Health Insurance and Services Company Streamlines Claims Processing with Kofax Mobile Capture Platform
BusinessWire - Wed May 06, 7:00AM CDT
Kofax(R) Limited (NASDAQ: KFX), a leading provider of smart process applications to simplify and transform the First Mile(TM) of customer engagement, today announced that a leading global health insurance and services company will deploy Kofax Mobile Capture(TM) Platform to enable insureds to submit medical claims via mobile devices. The solution is expected to streamline the claim submission and approval process for both insureds and the insurer, transforming a historically time consuming, error prone process into one that is quicker, easier and more accurate.
KFX: 11.01 (+0.02)

Kofax Kapow 9.5 Adds Analytics and Simulation Capabilities
BusinessWire - Thu Apr 30, 7:00AM CDT
Kofax(R) Limited (NASDAQ: KFX), a leading provider of software to simplify and transform the First Mile(TM) of customer engagement, today announced the availability of Kofax Kapow(TM) 9.5, a new version of the Company's information integration and automation platform. Kapow 9.5 now includes analytics capabilities that deliver out-of-the-box dashboards to provide comprehensive insight into information, processes and performance to enable better decisions sooner. Users can monitor and analyze information being processed, process workflows and system performance. Kapow 9.5 also now offers simulation capabilities that allow developers to test projects in real time prior to their deployment in a production environment.
KFX: 11.01 (+0.02)

Major U.S. Insurance Company Invests More Than $500,000 in Kofax Mobile Capture Platform
BusinessWire - Thu Apr 23, 7:11AM CDT
Kofax(R) Limited (NASDAQ: KFX), a leading provider of software to simplify and transform the First Mile(TM) of customer engagement, today announced that a top five U.S. property and casualty insurance company has invested more than $500,000 in Kofax Mobile Capture(TM) Platform, Kofax Mobile Capture SDK and Kofax Mobile ID(TM) to provide its customers with a superior mobile customer experience. This purchase marks the second major insurance company to adopt Kofax Mobile Capture Platform in 2015.
KFX: 11.01 (+0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading